Advancing the Development of Imsidolimab with AnaptysBio

2020-07-09

We are excited to share some good news! Congratulations AnaptysBio on the orphan drug designation of imsidolimab for the treatment of GPP! We are thrilled to manage this clinical trial and help advance the development of imsidolimab.

For more information on our services, visit https://innovaderm.com/full-service-dermatology-cro/

About Anaptys:

AnaptysBio is a clinical-stage antibody development company advancing therapeutic antibody product candidates focused on unmet medical needs in inflammation.

Newsletter

Join our science community with Press Forward, our quarterly newsletter. Get the latest in dermatology clinical research. Subscribe now!

Newsletter subscription resources

*By subscribing to our newsletter, you acknowledge and agree to the terms of our privacy policy.

Join Innovaderm at the AID’s Dermatology Summit in San Francisco!

We are excited to announce our participation in the upcoming AID’s Dermatology Summit in San Francisco, taking place on January 12th, 2025. This prestigious event brings together leading experts, researchers, and practitioners in the field of dermatology to share the latest advancements and innovations. As long-time sponsors of this summit, we are proud to continue […]

Innovaderm Research Appoints Ina Zschocke as New Executive Vice President, European Operations and Strategy

[MONTREAL, QC, November 19th, 2024]—Innovaderm, a leading clinical research organization (CRO) specializing in dermatology and rheumatology, is pleased to announce the appointment of Ina Zschocke, as the new Executive Vice President, European Operations and Strategy. This strategic hire underscores Innovaderm’s commitment to expanding its ever-growing presence and capabilities in the European market. Ina Zschocke, PhD, […]

Innovaderm's CMO Will be Chairing the Clinical Outsourcing Group: CRO Summit!

Innovaderm is thrilled to announce that it's Chief Medical Officer, Dr. Jasmina Jankicevic, will be chairing Pharmaceutical Business Conference Group's (PBC Group) Clinical Outsourcing Group: CRO Summit on December 3rd & 4th, 2024. The Future of Clinical Research: Summit Chair Jasmina Jankicevic Weighs in on CRO Evolution - Read the interview now to learn on the changing environment for clinical […]

Advancing the Development of Imsidolimab with AnaptysBio

Newsletter subscription resources

Other recent articles

Join Innovaderm at the AID’s Dermatology Summit in San Francisco!

Innovaderm Research Appoints Ina Zschocke as New Executive Vice President, European Operations and Strategy

Innovaderm's CMO Will be Chairing the Clinical Outsourcing Group: CRO Summit!